US · Healthcare

Genfit SA Sponsored ADR (GNFTY)

Biotechnology

Genfit SA Sponsored ADR (GNFTY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for GNFTY

P/E ratio

25.00

Genfit SA Sponsored ADR (GNFTY) — FAQ

What is GNFTY's P/E ratio?

The price-to-earnings (P/E) ratio for Genfit SA Sponsored ADR (GNFTY) is 25.00 (data as of 2026-05-23).

Does Genfit SA Sponsored ADR pay a dividend?

Dividend yield is not available in the current snapshot for Genfit SA Sponsored ADR (GNFTY). Check the MyAverix Finance app for the latest dividend data.

What sector is Genfit SA Sponsored ADR in?

Genfit SA Sponsored ADR (GNFTY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is GNFTY listed on?

GNFTY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)